Immune Cell Stimulation and Cytokine Release Assay

Excessive activation or suppression of immune cells is an important factor in the occurrence and development of immune diseases. Primary immune cell experiments can more accurately reflect the activity of antibody drugs in vivo. Primary immune cells (PBMCs, T cells, NK cells, etc.) can be stimulated by various activators such as CD3/CD28, IL2, PHA, LPS, SEB, SEA, DC, and others, or through mixed lymphocyte response (MLR). Evaluating the activation or inhibition effects of antibody drugs on immune cells by detecting cytokine release, immune cell proliferation, or cell surface marker expression is an important method for in vitro screening of antibody activity.


图片3.png


Case: The evaluation of the activation effect of Pembrolizumab on T cells.


图片7.png图片8.png

Fig1. Pembrolizumab enhanced IL-2 and IFN-γ productions

in PBMC stimulated by SEB


图片9.png图片4.png

Fig2. Pembrolizumab enhanced IL-2 and IFN-γ productions in MLR assay


GPT Advantages


  • Extensive library of target cells (over 300 cancer cell lines and humanized cell lines) in BSL-2 level laboratories.

  • Free provision of comparator antibody therapy for common viral infections.

  • Two available systems: induced DCs and commercialized DCs.

  • Abundant PBMC donors with locking support.

  • Extensive project experience.

  • Meets regulatory requirements for new drug application submissions.

  • Adherence to strict laboratory data storage standards for experiment traceability.




TALK WITH OUR EXPERTS

GemPharmatech is committed to protecting and respecting your privacy, and we'll only use your personal information to administer your account and to provide the products and services you requested from us. From time to time, we would like to contact you about our products and services, as well as other content that may be of interest to you. If you consent to us contacting you for this purpose, please click below to say how you would like us to contact you:

In order to provide you with the content requested, we need to store and process your personal data. If you consent to us storing your personal data for this purpose, please click the checkbox below.

You can unsubscribe from these communications at any time. For more information on how to unsubscribe, our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Policy.